Are We Heading Toward a Recession?
Fears of a recession in 2025 grew at the end…
Buy
66
DXCM Quote, Financials, Valuation and Earnings
Last price:
$84.67
Seasonality move
:
13.1%
Day range:
$84.23 - $85.71
52-week range:
$57.52 - $132.26
Dividend yield:
0%
P/E ratio:
63.19x
P/S ratio:
8.38x
P/B ratio:
14.65x
Volume:
3.3M
Avg. volume:
4.9M
1-year change:
-33.92%
Market cap:
$33.2B
Revenue:
$4B
EPS (TTM):
$1.34
DexCom SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
DXCM
DexCom
|
04/25/2024 | 10-Q | 10-Q filing on 04/25/2024 | View Form |
|
DXCM
DexCom
|
10/26/2023 | 10-Q | 10-Q filing on 10/26/2023 | View Form |
|
DXCM
DexCom
|
07/27/2023 | 10-Q | 10-Q filing on 07/27/2023 | View Form |
|
DXCM
DexCom
|
04/27/2023 | 10-Q | 10-Q filing on 04/27/2023 | View Form |
|
DXCM
DexCom
|
10/27/2022 | 10-Q | 10-Q filing on 10/27/2022 | View Form |
|
DXCM
DexCom
|
07/28/2022 | 10-Q | 10-Q filing on 07/28/2022 | View Form |
|
DXCM
DexCom
|
04/28/2022 | 10-Q | 10-Q filing on 04/28/2022 | View Form |
|
DXCM
DexCom
|
10/28/2021 | 10-Q | 10-Q filing on 10/28/2021 | View Form |
|
DXCM
DexCom
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
DXCM
DexCom
|
04/29/2021 | 10-Q | 10-Q filing on 04/29/2021 | View Form |
|
DXCM
DexCom
|
02/11/2021 | 10-K | 10-K filing on 02/11/2021 | View Form |
|
DXCM
DexCom
|
10/27/2020 | 10-Q | 10-Q filing on 10/27/2020 | View Form |
|
DXCM
DexCom
|
07/28/2020 | 10-Q | 10-Q filing on 07/28/2020 | View Form |
|
DXCM
DexCom
|
04/28/2020 | 10-Q | 10-Q filing on 04/28/2020 | View Form |
|
DXCM
DexCom
|
02/13/2020 | 10-K | 10-K filing on 02/13/2020 | View Form |
|
DXCM
DexCom
|
11/06/2019 | 10-Q | 10-Q filing on 11/06/2019 | View Form |
|
DXCM
DexCom
|
07/31/2019 | 10-Q | 10-Q filing on 07/31/2019 | View Form |
|
DXCM
DexCom
|
05/01/2019 | 10-Q | 10-Q filing on 05/01/2019 | View Form |
|
DXCM
DexCom
|
02/21/2019 | 10-K | 10-K filing on 02/21/2019 | View Form |
|
DXCM
DexCom
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
DXCM
DexCom
|
08/01/2018 | 10-Q | 10-Q filing on 08/01/2018 | View Form |
|
DXCM
DexCom
|
05/02/2018 | 10-Q | 10-Q filing on 05/02/2018 | View Form |
|
DXCM
DexCom
|
02/27/2018 | 10-K | 10-K filing on 02/27/2018 | View Form |
|
DXCM
DexCom
|
11/01/2017 | 10-Q | 10-Q filing on 11/01/2017 | View Form |
|
DXCM
DexCom
|
08/01/2017 | 10-Q | 10-Q filing on 08/01/2017 | View Form |
|
DXCM
DexCom
|
05/02/2017 | 10-Q | 10-Q filing on 05/02/2017 | View Form |
|
DXCM
DexCom
|
02/28/2017 | 10-K | 10-K filing on 02/28/2017 | View Form |
|
DXCM
DexCom
|
11/01/2016 | 10-Q | 10-Q filing on 11/01/2016 | View Form |
|
DXCM
DexCom
|
08/02/2016 | 10-Q | 10-Q filing on 08/02/2016 | View Form |
|
DXCM
DexCom
|
04/27/2016 | 10-Q | 10-Q filing on 04/27/2016 | View Form |
|
DXCM
DexCom
|
02/23/2016 | 10-K | 10-K filing on 02/23/2016 | View Form |
|
DXCM
DexCom
|
11/04/2015 | 10-Q | 10-Q filing on 11/04/2015 | View Form |
|
DXCM
DexCom
|
08/05/2015 | 10-Q | 10-Q filing on 08/05/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
